Integrating Divergence-Based Proteomic Analysis and Directed Network Diffusion to Characterize Diagnosis-Anchored Molecular Variability at the Metabolic Syndrome–Migraine Interface
Open Access
- 27 May 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (11) , 4820
Abstract
Metabolic syndrome (MetS) has been associated with migraine, but the prediagnostic phase and the molecular features preceding migraine onset remain unclear. We aimed to identify a diagnosis-anchored proteomic variability window and to characterize pathways, candidate bridge proteins, and druggable targets within a direction-consistent MetS-to-migraine molecular framework. We first assessed the association between baseline MetS and incident migraine in 452,471 UK Biobank participants using Cox models. We then conducted a nested proteomics case–control analysis stratified by MetS status and applied single-sample Jensen–Shannon divergence (sJSD), network proximity, directed diffusion, and drug–target proximity analyses. Baseline MetS was associated with a higher risk of incident migraine (hazard ratio 1.09, 95% confidence interval (CI) 1.01–1.18; p = 0.022). A diagnosis-anchored proteomic divergence pattern peaked 4.71–6.76 years before migraine diagnosis in the MetS stratum. The parallel within-stratum analysis in the NoMetS stratum showed no T2-centered peak. We identified 11 direction-consistent novel pathways, seven candidate bridge proteins spanning metabolic, endothelial, and brain tissues, and three candidate drugs. These findings support a diagnosis-stratified framework for studying MetS-related migraine and provide testable hypotheses for future mechanistic and pharmacological evaluation.Keywords
Funding Information
- National Natural Science Foundation of China (82505235)
- Beijing University of Chinese Medicine (90011451310085)
This publication has 48 references indexed in Scilit:
- Identifying critical transitions in complex diseasesJournal of Biosciences, 2022
- Genetic overlap and causality between blood metabolites and migraineThe American Journal of Human Genetics, 2021
- Sex differences in the epidemiology, clinical features, and pathophysiology of migraineThe Lancet Neurology, 2017
- bFGF Protects Against Blood-Brain Barrier Damage Through Junction Protein Regulation via PI3K-Akt-Rac1 Pathway Following Traumatic Brain InjuryMolecular Neurobiology, 2015
- Terazosin activates Pgk1 and Hsp90 to promote stress resistanceNature Chemical Biology, 2014
- Early-warning signals for critical transitionsNature, 2009
- Linear polyubiquitination: a new regulator of NF‐κB activationEMBO Reports, 2009
- Inhibition of Src Activity Decreases Tyrosine Phosphorylation of Occludin in Brain Capillaries and Attenuates Increase in Permeability of the Blood-Brain Barrier after Transient Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2009
- The metabolic syndrome—a new worldwide definitionThe Lancet, 2005
- Nuclear factor‐κB as a molecular target for migraine therapyAnnals of Neurology, 2002